PCT Research GuideHPTA Axis Restoration After AAS — Complete Research Reference by QSC Peptides

All exogenous AAS suppress the Hypothalamic-Pituitary-Testicular Axis (HPTA) — the hormonal feedback system that governs endogenous testosterone production. This suppression occurs via two converging mechanisms:

1. Direct AR feedback at hypothalamus: Exogenous androgens activate hypothalamic AR, suppressing GnRH pulse generation. GnRH drives LH and FSH release from the pituitary — without GnRH pulses, LH/FSH fall to near-zero.
2. E2 feedback (for aromatizing AAS): Aromatizing AAS (Testosterone, Dianabol) convert to estradiol, which acts at hypothalamic ER to provide additional negative feedback suppressing GnRH. This is why non-aromatizing AAS (Trenbolone, Anavar) suppress HPTA via AR alone.

Without LH, Leydig cells in the testes cease testosterone production. Without FSH, Sertoli cells cease spermatogenesis support. Duration and severity of suppression varies by compound:

• Strongest suppressors: Trenbolone (AR + PR + potent), MENT (AR + PR + aromatization), Testosterone (AR + E2)
• Moderate suppressors: Nandrolone (AR + PR + minimal E1), Dianabol (AR + MeE2)
• Weaker suppressors: Anavar (pure AR, no aromatization), low-dose Masteron

PCT Compound Mechanisms

Clomiphene (Clomid) and Tamoxifen (Nolvadex) — Selective Estrogen Receptor Modulators (SERMs) — block ER at the hypothalamus and pituitary. The brain perceives low estrogen → increases GnRH pulses → increases LH/FSH → testes resume testosterone and sperm production. This is the core HPTA restoration mechanism.

Aromasin (Exemestane) — irreversible aromatase inhibitor — reduces estrogen production by blocking CYP19A1 permanently (per dose), removing the E2-mediated feedback component. Useful when aromatizing AAS have been used.

Anastrozole (Arimidex) — reversible competitive aromatase inhibitor — reduces E2 production without permanent enzyme inactivation. Rapid reversal upon discontinuation.

HCG — acts directly on Leydig cell LH/hCG receptors, stimulating testosterone production independent of the hypothalamic-pituitary axis. Useful for testicular maintenance during suppression or for direct testicular stimulation research.

Research Protocol Design

• SERM monotherapy: Clomid or Nolvadex alone — studies HPTA restoration via hypothalamic ER blockade without E2 reduction
• AI + SERM: Combined estrogen reduction (AI) + hypothalamic ER block (SERM) — additive HPTA restoration for aromatizing AAS protocols
• HCG + SERM: Direct Leydig stimulation (HCG) + pituitary restoration (SERM) — studies combined testicular recovery mechanisms
• Full tri-compound PCT: SERM + AI + HCG — comprehensive protocol for maximum HPTA recovery rate studies